SolriamfetolA Study to Assess the Efficacy and Safety of Solriamfetol in Adolescents With ADHD

Sponsor:

Axsome Therapeutics, Inc.

Code:

NCT07717892

Conditions

ADHD

Eligibility Criteria

Sex: All

Age: 12 - 17

Healthy Volunteers: Not accepted

Interventions

Solriamfetol Dose A

Solriamfetol Dose B

Placebo

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2026-08-20. This information was provided to ClinicalTrials.gov by Axsome Therapeutics, Inc. on 2026-07-21.